DXC Q1 2026 Earnings EPS Surpasses Estimates as Cost Actions Drive Profitability Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss Meets Optimism in Gene Therapy Pipeline MXCT Q1 2026 Earnings EPS Surprise Beats Estimates by 51 Shares Rally 8 HCWC Q4 2025 Earnings Narrow Beat on EPS Provides Modest Relief Amid Stalled Revenue Disclosure PCSA Q4 2025 Earnings EPS Misses Estimates Amid Pipeline Development MWA Q1 2026 Earnings Mueller Water Products Beats on EPS Despite Revenue Pressure